In this podcast episode, Dr. Erandi De Silva discusses the hybrid approach to gene therapy development at Forge Biologics, Inc., an emerging leader in the contract development and manufacturing (CDMO) market for advanced regenerative medicine products. Dr. De Silva also discusses the unique approach to building a culture and diverse talent pool within the Columbus, Ohio biotech ecosystem.